Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine | 370 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
04.07. | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares as fee payments to directors | 1 | Stockwatch | ||
03.07. | Rapid Dose Therapeutics Corp: Rapid Dose Therapeutics issues shares for interest | 2 | Stockwatch | ||
03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 527 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 454 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
02.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study | 233 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
03.06. | Rapid Dose Therapeutics Corp: Rapid Dose closes debt settlement, issues 1.88M shares | 2 | Stockwatch | ||
02.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors | 339 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has... ► Artikel lesen | |
RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
28.05. | PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller | 272 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics Inc.: Partnerschaft mit... ► Artikel lesen | |
28.05. | Rapid Dose Therapeutics Corp.: Partnerschaft mit weltweit führendem Tabakhersteller | 426 | IR-WORLD | BURLINGTON, ON - 26. Mai 2025 - Rapid Dose Therapeutics Corp. ("RDT" oder das "Unternehmen") (CSE: DOSE), ein kanadisches Biowissenschaftsunternehmen, das sich
auf innovative Lösungen für die... ► Artikel lesen | |
28.05. | Rapid Dose Therapeutics Corp: Rapid Dose arranges $3-million private placement | 3 | Stockwatch | ||
27.05. | Rapid Dose Therapeutics announces proposed equity private placement financing of up to $3M | 2 | Seeking Alpha | ||
27.05. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Equity Private Placement Financing | 365 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing... ► Artikel lesen | |
27.05. | Rapid Dose Therapeutics Corp: Rapid Dose files nicotine delivery patent applications | 4 | Stockwatch | ||
27.05. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology | 496 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 26, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company specializing in innovative drug delivery... ► Artikel lesen | |
22.05. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Advances QuickStrip Technology for Use in Dentistry | 346 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
16.05. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics entwickelt neues Anästhesie-Hilfsmittel für Zahnarztpraxen | 349 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics entwickelt neues Anästhesie-Hilfsmittel für Zahnarztpraxen
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics... ► Artikel lesen | |
12.05. | Rapid Dose Therapeutics issues shares to cut debt | 2 | Seeking Alpha | ||
10.05. | Rapid Dose Therapeutics Corp: Rapid Dose to issue up to 2.5 million shares for debts | 4 | Stockwatch | ||
10.05. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Debt Settlement | 733 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors")... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 96,15 | +1,53 % | Novo Nordisk, BioNxt Solutions, BioNTech - so heilen Sie Ihr Portfolio mit der Gesundheits-Revolution 2025 | Das globale Gesundheitswesen erlebt 2025 eine Zeitenwende. Klimafolgen, chronische Krankheiten und Pandemienarben fordern Systeme heraus, während Digitalisierung und KI rasant neue Therapien vorantreiben.... ► Artikel lesen | |
CLINUVEL | 6,475 | -4,85 % | EQS-News: Parmantier & Cie. GmbH: CLINUVEL Update: CEO Comeback & US Expansion Drive: Vitiligo-Zulassung und M&A als Wachstumstreiber in Nordamerika | EQS-News: Parmantier & Cie. GmbH
/ Schlagwort(e): Research Update
CLINUVEL Update: CEO Comeback & US Expansion Drive: Vitiligo-Zulassung und M&A als Wachstumstreiber in Nordamerika... ► Artikel lesen | |
BIONXT SOLUTIONS | 0,350 | -1,41 % | BioNxt berichtet über positive Ergebnisse aus seinem Programm zum patentierten sublingualen Cladribin-Schmelzfilm und schließt Formulierung erfolgreich ab | VANCOUVER, BC / ACCESS Newswire /
23. Juli 2025 / BioNxt Solutions Inc. ("BioNxt" oder das "Unternehmen") (CSE: BNXT) (OTC PINK: BNXTF) (FWB: BXT), ein auf fortschrittliche
Arzneimittelverabreichungssysteme... ► Artikel lesen | |
AMYRIS | - | - | Amyris gains sole control of Brazilian fermentation facility | ||
ATAI LIFE SCIENCES | 3,228 | +7,60 % | Atai Life Sciences: NBC-Trader sacken +26% in Kürze ein! | Einmal mehr demonstriert Chefanalyst Maximilian Ruth sein Können und liefert Mitgliedern des No Brainer Club mit der Aktie von Atai Life Sciences satte zweistellige Kursgewinne in Windeseile. Empfehlung... ► Artikel lesen | |
VIDAC PHARMA | 0,500 | +1,42 % | DAX-Korrektur! BioTech Im Übernahme-Modus! BioNTech, CureVac, Pfizer, Vidac Pharma und Kraft Heinz im Fokus | Die Aktienmärkte zeigen sich in Bestform: Sowohl der DAX als auch der NASDAQ 100 haben in den vergangenen Tagen Muskeln gezeigt. Angetrieben werden die Kurse vor allem von der anhaltenden Stärke der... ► Artikel lesen | |
SOL GLOBAL INVESTMENTS | 0,052 | +6,60 % | SOL Global Investments Corp.: SOL Global Announces Listing on OTC Markets Under OTCID: SOLCF | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") is pleased to announce that its common shares... ► Artikel lesen | |
MUSTGROW BIOLOGICS | 0,530 | 0,00 % | MustGrow Biologics Corp. Announces Results of Shareholder Meeting | Saskatoon, Saskatchewan--(Newsfile Corp. - June 26, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its... ► Artikel lesen | |
ENTHEON BIOMEDICAL CORP | 0,058 | +0,87 % | Entheon Biomedical Corp.: Entheon Announces Change of Directors | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands... ► Artikel lesen | |
TVARDI THERAPEUTICS | 21,050 | -2,32 % | XFRA 69C: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
REVIVE THERAPEUTICS | 0,016 | 0,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure | TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
CYBIN | 6,700 | +2,29 % | Cybin Inc.: Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder | - EMBRACE, the second Phase 3 study within the PARADIGM program, expects to enroll 330 participants at approximately 60 clinical sites across the United States, Europe and Australia and will... ► Artikel lesen | |
ARTELO BIOSCIENCES | 15,000 | +5,86 % | ARTELO BIOSCIENCES, INC. - 8-K, Current Report | ||
LOBE SCIENCES | 0,015 | -23,68 % | Lobe Sciences Ltd. Announces Debt Settlement | VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company committed to developing innovative treatments for underserved diseases... ► Artikel lesen | |
QIAGEN | 42,730 | +2,82 % | QIAGEN N.V.: QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels | Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NGS platforms such as PacBio for applications... ► Artikel lesen |